Company / Current Assets
United Therapeutics Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$3.7B
FY2025
5-year range
$2.3B / $3.9B
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
#23 of 213
Health Care
What the data says
United Therapeutics's current assets of $3.7B is higher than 89% of companies in the Health Care sector (FY2025). Improved from $3.6B to $3.7B over the past 2 years.
Based on SEC 10-K filings.
$3.7B in FY2025 with a 5-year CAGR of +11.3%. Top quartile in the Health Care sector.
Improved from $3.6B to $3.7B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +11.3%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 213This company $3.7B Sector average $2.5B
▼
+46.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +11.3%, indicating consistent growth.
- In FY2025, current assets decreased 4.4% year-over-year.
- Ranks #23 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.7B | -4.4% |
| FY2024 | $3.9B | +9.1% |
| FY2023 | $3.6B | +5.0% |
| FY2022 | $3.4B | +45.5% |
| FY2021 | $2.3B | +7.2% |
| FY2020 | $2.2B | +16.2% |
| FY2019 | $1.9B | +5.5% |
| FY2018 | $1.8B | +22.1% |
| FY2017 | $1.4B | +1.6% |
| FY2016 | $1.4B | +11.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026